Safi Biotherapeutics, a biotech company producing stem-cell derived, manufactured human red blood cell (mRBC) products for civilian and military transfusion needs, and ARMI | BioFabUSA , a non-profit organization and Department of Defense Manufacturing Innovation Institute, today announced a collaboration focused on the manufacturing of Safi’s...
announced 17 new projects designed to drive the scale-up and commercialization of American biomanufactured products. They include producing biodegradable plastics, upcycling waste to create new products, certification programs to prepare the workforce of tomorrow’s U.S. bioeconomy, developing cell-free systems for commodity chemicals and...
Biopharma’s drug quality efforts are hindered by a lack of data uniformity in the supply chain according to the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), which has teamed up with Open Applications Group (OAGi) to encourage the adoption of common standards.
The partnership—announced in —will focus on a...
A major investment is coming to New Hampshire to get a cutting-edge industry off the ground.
U.S. Commerce Secretary Gina Raimondo visited BioFabUSA in Manchester on Friday to discuss the grant, which will help the program develop human tissue that's suitable for transplants.
"What's happening here at BioFab is incredible," Raimondo said. "It's...
Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced that CEO Jeff Ross will be a keynote speaker at BioFabUSA’s 2022 Fall Summit from the Advanced Regenerative Manufacturing Institute (ARMI).
Mr. Ross...
